SIAMAK ETEHAD: Open Payments
NPI 1184728479 · NORTHRIDGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,397 in 54 payments from 15 companies in 2025. Trend: 2023 $1,224 · 2024 $3,227 · 2025 $1,397
Food & beverage: $995Speaker / faculty: $360Education: $43
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $562 |
| AstraZeneca Pharmaceuticals LP | 5 | $132 |
| GlaxoSmithKline, LLC. | 4 | $119 |
| Aimmune Therapeutics, Inc. | 3 | $86 |
| Exact Sciences Corporation | 3 | $71 |
| E.R. Squibb & Sons, L.L.C. | 3 | $67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $62 |
| Lundbeck LLC | 3 | $57 |
| Sumitomo Pharma America, Inc. | 2 | $55 |
| Mannkind Corporation | 1 | $43 |
Products named: FARXIGA, TRELEGY ELLIPTA, JARDIANCE, VRAYLAR, Cologuard Collection Kit, CREON, REXULTI, ZENPEP.
Industry payments across CA — which companies pay providers there.
